IP Library Patent Application 15248195
Patent Application
App. No. 15/248,195

ACTIVE INGREDIENTS STIMULATING TYPE 2 AND/OR TYPE 3 HUMAN BETA-DEFENSINS AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH ACTIVE INGREDIENTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/248,195
Abstract

The invention relates to active ingredients capable of stimulating direct or indirect expression of type 2 human beta-defensins and/or type 3 human beta-defensins. The invention thus provides an active ingredient capable of stimulating direct or indirect expression of type 2 human beta-defensins and/or type 3 human beta-defensins, characterized in that the active ingredient does not cause any inflammatory, irritation or intolerance reactions. The invention also provides a screening method for the selection of such active ingredients. The invention is applicable to the preparation of cosmetic or pharmaceutical compositions containing such active ingredients.

Claims (10)

1 . (canceled)

2 . A method of exerting a bactericidal and/or fungicidal effect on a tissue, said method comprising topically applying on a tissue of a subject in need thereof a cosmetic composition comprising between 0.1% and 1% (w/w) of an aqueous boldo extract obtained by extraction in water and at least one cosmetically acceptable excipient, wherein said cosmetic composition is applied in an amount effective to exert a bactericidal and/or fungicidal effect on the tissue and to stimulate expression of human beta-defensin 2 (hBD2) and/or human beta-defensin 3 (hBD3) in the tissue.

3 . The method of claim 2 , wherein the amount of the cosmetic composition applied does not act to stimulate inflammatory, irritation, or intolerance reactions in the tissue.

4 . The method of claim 2 , wherein the tissue is skin, hair, nails, and/or scalp.

5 . The method of claim 2 , wherein the tissue is inflicted by a disorder selected from the group consisting of dandruff, acne, vitiligo, bacterial dermatosis, and fungicidal dermatosis.

6 . The method of claim 2 , wherein said cosmetic composition further comprises at least one microbiocidal and/or microbio static agent.

7 . The method of claim 2 , wherein said cosmetic composition comprises 0.1% (w/w) of the aqueous boldo extract.

8 . The method of claim 2 , wherein said cosmetic composition comprises 0.5% (w/w) of the aqueous boldo extract.

9 . The method of claim 2 , wherein said cosmetic composition comprises 1% (w/w) of the aqueous boldo extract.

10 . The method of claim 2 , wherein the cosmetic composition is adapted to a galenic form selected from the group consisting of an aqueous solution, a lotion-type dispersion, a two-phase dispersion, a water/oil or oil/water emulsion, a triple emulsion, a vesicle dispersion, creams, milks, liquid soaps, a body emulsion, dermatological bars, a serum, a mousse, an aerosol, a stick, a make-up product for the skin, and a cleansing product for the skin, hair, nails, and/or scalp.